Please login to the form below

Not currently logged in
Email:
Password:

Takeda’s dengue vaccine receives MHRA approval for those aged four years and older

Takeda

An estimated 3.9 billion people globally are currently at risk of dengue, a mosquito-borne viral disease

Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis

Sandoz NovartisMore than ten million adults in the US alone over the age of 50 are estimated to have the condition

Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients

Novartis buildingAn estimated one in 100 people globally are affected by the inflammatory skin disease

NHS urges people yet to receive their COVID-19 booster to come forward

nhsSunday 12 February is the last day people under 50 years of age who are not considered at risk can receive a booster

Gilead’s Trodelvy approved by FDA for metastatic breast cancer

GileadHR+/HER2- is the most common type of breast cancer, accounting for 70% of new cases

World Health Organization releases new road map for breast cancer

WHO building logo.jpgNearly 80% of breast and cervical cancer deaths occur in low- and middle-income countries

Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer

Merck & Co HQEndometrial cancer is the sixth most common cancer in women worldwide

AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer

AZ NEWAround 210,000 people worldwide are diagnosed with the disease each year

ICR calls for improved biomarker cancer tests to help personalise treatment

Institute for Cancer ResearchEach cancer has a unique pattern of biomarkers that can affect how effective treatments are

Claire GillisQ&A: Claire Gillis

PME interviews VMLY&Rx's CEO

Latest appointments

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wave Healthcare Communications

Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...